Plantik Biosciences

Plantik Biosciences

Private
ParisHealthcare & Life Scienceshttps://www.plantik.bio/

Last Round

Accelerator

Nov 13, 2024

Total Funding Raised

$2.1M

Momentum Score

50 /100

Company Overview

Plantik Biosciences is an agritech company that develops climate-resilient crops using next-generation plant engineering and genome-editing technologies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Application

Keywords

genome editingagricultural biotechnologyCRISPRagtechclimate-resilient cropplant engineeringgene editingtrait developmentgenome analysis platformheat-tolerant cropplant breeding technologydark genome analysistrait licensingthermotolerant trait

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Plantik Biosciences Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Plantik Biosciences Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
AcceleratorNov 13, 2024
SeedFeb 6, 2024
GrantSep 13, 2022
AcceleratorJan 5, 2022
AcceleratorSep 10, 2020
Accelerator
Apr 8, 2020

Key People

Founding team and executive leadership

Ying Shao

Co-Founder & CEO

Founding Team

Plantik Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors grew 96% MoM.

  • Feb 19, 2026

    Grew 50% QoQ from 6 to 9 employees.

Plantik Biosciences Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Plantik Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Plantik Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range10
Year Founded2019
Last FundingNov 13, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.